Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| B cell | 21 studies | 24% ± 8% | |
| endothelial cell | 20 studies | 33% ± 12% | |
| macrophage | 16 studies | 30% ± 13% | |
| naive B cell | 13 studies | 21% ± 4% | |
| oligodendrocyte | 13 studies | 34% ± 14% | |
| astrocyte | 13 studies | 33% ± 16% | |
| fibroblast | 12 studies | 23% ± 8% | |
| microglial cell | 11 studies | 39% ± 12% | |
| GABAergic neuron | 10 studies | 42% ± 23% | |
| glutamatergic neuron | 10 studies | 52% ± 23% | |
| oligodendrocyte precursor cell | 10 studies | 33% ± 14% | |
| myeloid cell | 9 studies | 31% ± 13% | |
| adipocyte | 9 studies | 30% ± 8% | |
| neuron | 8 studies | 36% ± 17% | |
| memory B cell | 7 studies | 19% ± 3% | |
| dendritic cell | 7 studies | 21% ± 5% | |
| natural killer cell | 6 studies | 22% ± 4% | |
| interneuron | 6 studies | 48% ± 25% | |
| epithelial cell | 6 studies | 31% ± 9% | |
| retinal rod cell | 6 studies | 21% ± 5% | |
| mast cell | 6 studies | 25% ± 8% | |
| ciliated cell | 6 studies | 21% ± 5% | |
| basal cell | 6 studies | 23% ± 11% | |
| type II pneumocyte | 6 studies | 20% ± 4% | |
| retinal ganglion cell | 5 studies | 43% ± 15% | |
| amacrine cell | 5 studies | 30% ± 6% | |
| retina horizontal cell | 5 studies | 21% ± 4% | |
| retinal cone cell | 5 studies | 27% ± 6% | |
| cardiac muscle cell | 5 studies | 28% ± 6% | |
| Mueller cell | 5 studies | 30% ± 6% | |
| T cell | 5 studies | 21% ± 3% | |
| endothelial cell of lymphatic vessel | 5 studies | 28% ± 7% | |
| type I pneumocyte | 5 studies | 19% ± 4% | |
| club cell | 5 studies | 24% ± 7% | |
| smooth muscle cell | 5 studies | 24% ± 6% | |
| non-classical monocyte | 4 studies | 20% ± 5% | |
| granule cell | 4 studies | 27% ± 9% | |
| retinal bipolar neuron | 4 studies | 20% ± 3% | |
| retinal pigment epithelial cell | 4 studies | 32% ± 12% | |
| CD8-positive, alpha-beta T cell | 4 studies | 18% ± 2% | |
| lymphocyte | 4 studies | 31% ± 6% | |
| OFF-bipolar cell | 4 studies | 21% ± 6% | |
| ON-bipolar cell | 4 studies | 20% ± 4% | |
| monocyte | 4 studies | 30% ± 2% | |
| pericyte | 4 studies | 28% ± 7% | |
| effector memory CD8-positive, alpha-beta T cell | 3 studies | 18% ± 2% | |
| GABAergic interneuron | 3 studies | 33% ± 2% | |
| glial cell | 3 studies | 18% ± 2% | |
| CD16-positive, CD56-dim natural killer cell, human | 3 studies | 19% ± 3% | |
| immature B cell | 3 studies | 25% ± 1% | |
| precursor B cell | 3 studies | 21% ± 3% | |
| CD16-negative, CD56-bright natural killer cell, human | 3 studies | 19% ± 3% | |
| mononuclear phagocyte | 3 studies | 24% ± 5% | |
| GABAergic amacrine cell | 3 studies | 25% ± 6% | |
| glycinergic amacrine cell | 3 studies | 22% ± 3% | |
| rod bipolar cell | 3 studies | 24% ± 4% | |
| luminal hormone-sensing cell of mammary gland | 3 studies | 33% ± 6% | |
| hepatocyte | 3 studies | 38% ± 22% | |
| ependymal cell | 3 studies | 31% ± 14% | |
| megakaryocyte-erythroid progenitor cell | 3 studies | 25% ± 7% | |
| leukocyte | 3 studies | 29% ± 11% | |
| alveolar macrophage | 3 studies | 32% ± 7% | |
| transit amplifying cell | 3 studies | 26% ± 14% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 100% | 6927.03 | 2642 / 2642 | 100% | 38.06 | 704 / 705 |
| breast | 100% | 7255.86 | 459 / 459 | 100% | 65.89 | 1113 / 1118 |
| esophagus | 100% | 3526.91 | 1445 / 1445 | 99% | 18.98 | 181 / 183 |
| lung | 100% | 3730.64 | 577 / 578 | 99% | 15.65 | 1141 / 1155 |
| prostate | 100% | 5062.47 | 245 / 245 | 98% | 34.12 | 492 / 502 |
| thymus | 100% | 4060.07 | 653 / 653 | 98% | 19.03 | 590 / 605 |
| intestine | 100% | 4141.27 | 966 / 966 | 95% | 12.31 | 500 / 527 |
| skin | 100% | 3789.48 | 1808 / 1809 | 94% | 23.83 | 446 / 472 |
| stomach | 100% | 2834.29 | 359 / 359 | 94% | 14.13 | 270 / 286 |
| pancreas | 98% | 1791.14 | 320 / 328 | 97% | 14.77 | 172 / 178 |
| uterus | 100% | 4307.84 | 170 / 170 | 94% | 14.28 | 432 / 459 |
| kidney | 100% | 3382.42 | 89 / 89 | 94% | 17.00 | 846 / 901 |
| bladder | 100% | 4302.24 | 21 / 21 | 91% | 12.24 | 459 / 504 |
| adrenal gland | 100% | 4548.58 | 258 / 258 | 88% | 13.84 | 203 / 230 |
| ovary | 100% | 3753.28 | 180 / 180 | 84% | 9.11 | 361 / 430 |
| liver | 100% | 2208.91 | 226 / 226 | 71% | 7.72 | 290 / 406 |
| adipose | 100% | 4867.37 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 4884.86 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 100% | 7626.84 | 803 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 4596.61 | 241 / 241 | 0% | 0 | 0 / 0 |
| heart | 97% | 3460.89 | 836 / 861 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 97% | 20.46 | 28 / 29 |
| tonsil | 0% | 0 | 0 / 0 | 96% | 15.09 | 43 / 45 |
| eye | 0% | 0 | 0 / 0 | 83% | 15.11 | 66 / 80 |
| peripheral blood | 70% | 2710.35 | 646 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0006897 | Biological process | endocytosis |
| GO_0007165 | Biological process | signal transduction |
| GO_0061025 | Biological process | membrane fusion |
| GO_0016192 | Biological process | vesicle-mediated transport |
| GO_0006893 | Biological process | Golgi to plasma membrane transport |
| GO_0006915 | Biological process | apoptotic process |
| GO_0015031 | Biological process | protein transport |
| GO_1903441 | Biological process | protein localization to ciliary membrane |
| GO_0030139 | Cellular component | endocytic vesicle |
| GO_0055037 | Cellular component | recycling endosome |
| GO_0005769 | Cellular component | early endosome |
| GO_0031901 | Cellular component | early endosome membrane |
| GO_0032991 | Cellular component | protein-containing complex |
| GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
| GO_0005768 | Cellular component | endosome |
| GO_0042803 | Molecular function | protein homodimerization activity |
| GO_0019904 | Molecular function | protein domain specific binding |
| GO_0008083 | Molecular function | growth factor activity |
| GO_0005096 | Molecular function | GTPase activator activity |
| GO_0005515 | Molecular function | protein binding |
| Gene name | RABEP1 |
| Protein name | Rab GTPase-binding effector protein 1 (Rabaptin-4) (Rabaptin-5) (Rabaptin-5alpha) (Renal carcinoma antigen NY-REN-17) Rabaptin, RAB GTPase binding effector protein 1 RABEP1 protein |
| Synonyms | RAB5EP RABPT5A RABPT5 |
| Description | FUNCTION: Rab effector protein acting as linker between gamma-adaptin, RAB4A and RAB5A. Involved in endocytic membrane fusion and membrane trafficking of recycling endosomes. Involved in KCNH1 channels trafficking to and from the cell membrane . Stimulates RABGEF1 mediated nucleotide exchange on RAB5A. Mediates the traffic of PKD1:PKD2 complex from the endoplasmic reticulum through the Golgi to the cilium (By similarity). . |
| Accessions | ENST00000572250.1 ENST00000341923.10 [Q15276-2] I3L2B8 ENST00000574568.1 A0A087WZZ3 ENST00000570487.1 I3L456 K7ENJ9 ENST00000575991.1 Q05BX6 Q15276 ENST00000537505.6 [Q15276-1] |